Login / Signup

Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate.

Kim van KolRenée EbischJurgen M J PiekMaaike BeugelingTineke VergeldtRuud L M Bekkers
Published in: Cancers (2021)
there is no association found in the time between chemoradiation therapy and residual disease on adjuvant hysterectomy specimens. The survival rates after chemoradiation therapy and adjuvant hysterectomy are suboptimal, while the risk of complications after adjuvant hysterectomy is high.
Keyphrases
  • early stage
  • rectal cancer
  • locally advanced
  • stem cells
  • radiation therapy
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation